Tag: Oxford studying nasal spray coronavirus vaccine

The University of Oxford is studying a nasal spray version of the Oxford-AstraZeneca COVID-19 vaccine among 30 young, healthy volunteers, and will assess the induced immune response, safety and any side effects. The early-stage trial will enroll adults aged 18 to 40 from the Oxford area, and researchers will conduct four months of follow-up, according to a release posted Thursday. …